Track the 그린생명과학 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 그린생명과학 has published 30 public disclosures. Market capitalisation: €36.8bn. The latest transaction was disclosed on 22 June 2026 (Other). Among the most active insiders: 건덕상사. All data is openly available.
30
Insider Decl.
0
Thresholds
·
19 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,586 of 25,484 companies
19.1
score / 100
Value
23
Quality
15
FCF yld-2.2%
Earn yld0.3%
EV/EBITDA38.4x
ROE·
Gross mgn6.1%
Net mgn0.3%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Green Life Science is a company in the health and pharmaceutical sector listed on the XKRX market. It focuses on developing innovative solutions in the life sciences field.